Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,900 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2022) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


 (PDF, 6MB, 247 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website



Export 124 results:
Author Title Type [ Year(Desc)]
Filters: Author is van Staa, T. P.  [Clear All Filters]
T. P. van Staa, Card, T., Logan, R. F., and Leufkens, H. G., 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study, Gut, vol. 54, pp. 1573-8, 2005.
C. J. Edwards, Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., and Cooper, C., The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database, Rheumatology (Oxford), vol. 44, pp. 1394-8, 2005.
P. C. Souverein, Webb, D. J., Petri, H., Weil, J., van Staa, T. P., and Egberts, T., Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database, Epilepsia, vol. 46, pp. 304-10, 2005.
G. W. Hugenholtz, Heerdink, E. R., van Staa, T. P., Nolen, W. A., and Egberts, A. C., Risk of hip/femur fractures in patients using antipsychotics, Bone, vol. 37, pp. 864-70, 2005.
F. de Vries, van Staa, T. P., Bracke, M. S., Cooper, C., Leufkens, H. G., and Lammers, J. W., Severity of obstructive airway disease and risk of osteoporotic fracture, Eur Respir J, vol. 25, pp. 879-84, 2005.
T. P. van Staa, Geusens, P., Pols, H. A., de Laet, C., Leufkens, H. G., and Cooper, C., A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids, Qjm, vol. 98, pp. 191-8, 2005.
E. Setakis, Leufkens, H. G., and van Staa, T. P., Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib, Arthritis Rheum, vol. 59, pp. 1105-11, 2008.
T. P. van Staa, Rietbrock, S., Setakis, E., and Leufkens, H. G., Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?, J Intern Med, vol. 264, pp. 481-92, 2008.
T. P. van Staa, Smeeth, L., Persson, I., Parkinson, J., and Leufkens, H. G., Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?, Pharmacoepidemiol Drug Saf, vol. 17, pp. 475-84, 2008.
A. M. Gallagher, Rietbrock, S., Olson, M., and van Staa, T. P., Fracture outcomes related to persistence and compliance with oral bisphosphonates, J Bone Miner Res, vol. 23, pp. 1569-75, 2008.
T. P. van Staa, Cooper, C., Barlow, D., and Leufkens, H. G., Individualizing the risks and benefits of postmenopausal hormone therapy, Menopause, vol. 15, pp. 374-81, 2008.
A. M. Gallagher, Rietbrock, S., Plumb, J., and van Staa, T. P., Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?, J Thromb Haemost, vol. 6, pp. 1500-6, 2008.
T. P. van Staa, Smeeth, L., Persson, I., Parkinson, J., and Leufkens, H. G., What is the harm-benefit ratio of Cox-2 inhibitors?, Int J Epidemiol, vol. 37, pp. 405-13, 2008.
T. P. van Staa, Leufkens, H. G., Zhang, B., and Smeeth, L., A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example, PLoS Med, vol. 6, p. e1000194, 2009.
F. de Vries, Cooper, A. L., Cockle, S. M., van Staa, T. P., and Cooper, C., Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates, Osteoporos Int, vol. 20, pp. 1989-98, 2009.
S. Rietbrock, Plumb, J. M., Gallagher, A. M., and van Staa, T. P., How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database, Thromb Haemost, vol. 101, pp. 527-34, 2009.
B. Zhang, de Vries, F., Setakis, E., and van Staa, T. P., The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database, J Hypertens, vol. 27, pp. 1485-92, 2009.
S. Rietbrock, Olson, M., and van Staa, T. P., The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates, Qjm, vol. 102, pp. 35-42, 2009.
T. P. van Staa and Sprafka, J. M., Study of adverse outcomes in women using testosterone therapy, Maturitas, vol. 62, pp. 76-80, 2009.
[Page last reviewed 4 January 2022]